Carglumic acid 200 mg Tablet for Oral Suspension
RxNorm 905390
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 905390 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carglumic acid 200 mg Tablet for Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Carglumic acid 200 mg Tablet for Oral Suspension
(Atom ID: 12343413)
PTPrescribable
Designated preferred name (PT):
Carglumic acid 200 mg dispersible oral tablet
(Atom ID: 12871519)
SYPrescribable
Synonym (SY):
Carglumic acid 200 mg Dispersible Tablet for Oral Suspension
(Atom ID: 4241416)
PSNPrescribable
Prescribable Name (PSN):
Carglumic acid 200 mg Tablet for Oral Suspension
(Atom ID: 8704130)
SYPrescribable
Synonym (SY):
Carglumic acid 200 mg tablet for oral suspension
(Atom ID: 12871520)
FNPrescribable